economy
We're trimming a big winner and buying the dip in a stock that shouldn't be down
We are making two trades Wednesday.
TL;DR
- Jim Cramer's Charitable Trust is selling 15 shares of Goldman Sachs (GS) for a ~67% profit.
- The trust is buying 65 shares of Johnson & Johnson (JNJ) to increase its position.
- The sale of GS reduces its portfolio weight, while the purchase of JNJ increases it.
- JNJ's purchase is driven by positive, unnoticed news about its Ottava robotic surgery system achieving a milestone in clinical studies.
- Healthcare stocks are currently out of favor in an AI-driven market, but JNJ, along with other healthcare positions like Cardinal Health, is seen as a high-quality company with strong fundamentals.
- JNJ's MedTech products and drugs are expected to support double-digit revenue growth by the end of the decade.